FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
BACHA JEFFREY
  2. Issuer Name and Ticker or Trading Symbol
DelMar Pharmaceuticals, Inc. [DMPI]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
SUITE 720-999 WEST BROADWAY
3. Date of Earliest Transaction (Month/Day/Year)
12/22/2017
(Street)

VANCOUVER, A1 V5Z 1K5
4. If Amendment, Date Original Filed(Month/Day/Year)
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/31/2017   J(1)   176 A $ 3.2 63,873 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Options (Right to Buy) $ 2 12/22/2017   D(2)     37,500   (2) 02/01/2022(2) Common Stock 37,500 (2) 0 D  
Options (Right to Buy) $ 2 12/22/2017   A(2)   37,500   12/22/2017(2) 12/31/2020(2) Common Stock 37,500 (2) 37,500 D  
Options (Right to Buy) $ 4.2 12/22/2017   D(2)     87,500   (2) 08/15/2023(2) Common Stock 87,500 (2) 0 D  
Options (Right to Buy) $ 4.2 12/22/2017   A(2)   87,500   12/22/2017(2) 12/31/2020(2) Common Stock 87,500 (2) 87,500 D  
Options (Right to Buy) $ 4.95 12/22/2017   D(2)     93,600   (2) 02/17/2027(2) Common Stock 93,600 (2) 0 D  
Options (Right to Buy) $ 4.95 12/22/2017   A(2)   93,600   12/22/2017(2) 12/31/2020(2) Common Stock 93,600 (2) 93,600 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
BACHA JEFFREY
SUITE 720-999 WEST BROADWAY
VANCOUVER, A1 V5Z 1K5
  X      

Signatures

 /s/ Jeffrey Bacha   01/03/2018
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
(2) Effective January 1, 2018, the Reporting Person's employment with the Issuer terminated. Pursuant to the terms of the Settlement Agreement dated December 22, 2017 between the Reporting Person and the Issuer, all of the Reporting Person's outstanding stock options became fully vested and exercisable on December 22, 2017, and terminate December 31, 2020. The Reporting Person shall continue to serve as a member of the board of directors. The six reported transactions in Table II disclose the deemed cancellation of "old" options and the grant of replacement options resulting from the foregoing amendments to the options.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.